“UniCAR”-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
“UniCAR”-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-07
DOI
10.1038/s41598-020-59082-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy
- (2019) Jianguang Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The UniCAR system: A modular CAR T cell approach to improve the safety of CAR T cells
- (2019) Michael Bachmann IMMUNOLOGY LETTERS
- Adoptive cell therapy using engineered natural killer cells
- (2019) Katayoun Rezvani BONE MARROW TRANSPLANTATION
- Conventional CARs versus modular CARs
- (2019) Anja Feldmann et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor immunotherapy: New aspects of natural killer cells
- (2018) Yangxi Li et al. Chinese Journal of Cancer Research
- CAR T-cell Therapy: A New Era in Cancer Immunotherapy
- (2018) Miliotou N. Androulla et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy
- (2018) Shivani Srivastava et al. JOURNAL OF IMMUNOLOGY
- Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells
- (2018) L. R. Loureiro et al. Blood Cancer Journal
- CAR T Cell Therapy for Neuroblastoma
- (2018) Rebecca M. Richards et al. Frontiers in Immunology
- Anti-GD2 immunotherapy for neuroblastoma
- (2017) Sameer Sait et al. Expert Review of Anticancer Therapy
- Chimeric antigen receptor T cells: a novel therapy for solid tumors
- (2017) Shengnan Yu et al. Journal of Hematology & Oncology
- Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
- (2017) Nicola Mitwasi et al. Oncotarget
- The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
- (2017) John P. Veluchamy et al. Frontiers in Immunology
- Antibody or Antibody Fragments: Implications for Molecular Imaging and Targeted Therapy of Solid Tumors
- (2017) Katerina T. Xenaki et al. Frontiers in Immunology
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform
- (2017) Susann Albert et al. OncoImmunology
- Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults
- (2016) Konstantin Dobrenkov et al. PEDIATRIC BLOOD & CANCER
- Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions
- (2016) Tilman Schlothauer et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts
- (2016) M Cartellieri et al. Blood Cancer Journal
- NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy
- (2015) Garnet Suck et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Disialoganglioside GD2 as a therapeutic target for human diseases
- (2015) Maya Suzuki et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Practical NK cell phenotyping and variability in healthy adults
- (2015) Laura S. Angelo et al. IMMUNOLOGIC RESEARCH
- The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
- (2015) Katayoun Rezvani et al. Frontiers in Immunology
- Anti-GD2 strategy in the treatment of neuroblastoma
- (2014) R.K. Yang et al. DRUGS OF THE FUTURE
- A Novel Ex Vivo Isolation and Expansion Procedure for Chimeric Antigen Receptor Engrafted Human T Cells
- (2014) Marc Cartellieri et al. PLoS One
- IgG Subclasses and Allotypes: From Structure to Effector Functions
- (2014) Gestur Vidarsson et al. Frontiers in Immunology
- Are natural killer cells superior CAR drivers?
- (2014) Hans Klingemann OncoImmunology
- Treatment of patients with advanced cancer with the natural killer cell line NK-92
- (2013) Torsten Tonn et al. CYTOTHERAPY
- Module-assisted preparation of 64Cu with high specific activity
- (2012) S. Thieme et al. APPLIED RADIATION AND ISOTOPES
- Properties of mouse and human IgG receptors and their contribution to disease models
- (2012) P. Bruhns BLOOD
- Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model
- (2012) B. E. Swift et al. HAEMATOLOGICA
- Inhibition of Intracellular Antiviral Defense Mechanisms Augments Lentiviral Transduction of Human Natural Killer Cells: Implications for Gene Therapy
- (2012) Tolga Sutlu et al. HUMAN GENE THERAPY
- Novel Humanized and Highly Efficient Bispecific Antibodies Mediate Killing of Prostate Stem Cell Antigen-Expressing Tumor Cells by CD8+ and CD4+ T Cells
- (2012) A. Feldmann et al. JOURNAL OF IMMUNOLOGY
- Anti-CD3 × anti-GD2 bispecific antibody redirects T-cell cytolytic activity to neuroblastoma targets
- (2012) Maxim Yankelevich et al. PEDIATRIC BLOOD & CANCER
- Expression of GD2 and GD3 Gangliosides in Human Embryonic Neural Stem Cells
- (2011) Makoto Yanagisawa et al. ASN Neuro
- Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
- (2011) C. U. Louis et al. BLOOD
- NK cells engineered to express a GD2-specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin
- (2011) Ruth Esser et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Natural killer cell-produced IFN-γ and TNF-α induce target cell cytolysis through up-regulation of ICAM-1
- (2011) Ruipeng Wang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
- (2010) Marc Cartellieri et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Multivalent antibodies: when design surpasses evolution
- (2010) Ángel M. Cuesta et al. TRENDS IN BIOTECHNOLOGY
- Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells
- (2009) E. Yvon et al. CLINICAL CANCER RESEARCH
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
- (2008) Greg M. Thurber et al. ADVANCED DRUG DELIVERY REVIEWS
- Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
- (2008) S. Arai et al. CYTOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now